RxDoctor Payments Data

Tobin Stratman, PA

Physician Assistant · Glendale, AZNPI 1932398302

Payments from drug & device makers

$9,047in general payments, 2019–2025

Across 179 payments — averaging $50.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Nevro Corp.$2K
  • Abbott$2K
  • Globus Medical$388
  • Boston Scientific$385
  • AbbVie$280
  • plus $1K from 19 others

What the payments were for

  • Travel & lodging$3,85843%
  • Food & beverage$5,10256%
  • Education$871%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,047 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$64,914
Medicare patients
193
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine148$37,423
Xtampza ErOxycodone Myristate67$35,988
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,156$30,096
OxycontinOxycodone Hcl33$25,408
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen775$20,574
Gabapentin635$12,650
Oxycodone Hcl572$12,274
Pregabalin563$11,025
BelbucaBuprenorphine Hcl22$10,450
Morphine Sulfate ErMorphine Sulfate313$7,372
MovantikNaloxegol Oxalate11$6,093
Tizanidine Hcl348$4,721
Morphine Sulfate179$4,665
Oxymorphone Hcl ErOxymorphone Hcl12$4,497
Celecoxib162$4,037

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$214$46,43889 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl$76$43,804431 claims
Redhill Biopharma Inc.Movantik$25$6,09311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →